Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
MICROBIAL PRODUCTION - Cutting-Edge inABLE® Technology: The Key to Cost-Effective Production of a Novel Antimicrobial Peptide With Potential for the Treatment of MRSA
Ian Fotheringham, PhD, and Mathew Upton, PhD, report that Infections caused by antibiotic resistant bacteria are an ever-increasing threat to public health, creating an urgent, growing demand for the identification and development of new therapies.
Hebei Changshan Biochem Pharma & Albumedix Enter Development Agreement
Albumedix and Hebei Changshan Biochem Pharma Co. recently announced they have entered into a supply agreement for the development of...Patheon Selected by Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with...Patheon Selected By Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement...Capsugel & Pulmatrix Enter Collaboration to Develop & Manufacture Novel Inhaled Therapeutics
Capsugel and Pulmatrix, Inc. have recently formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The...NANOSCALE COMPLEXES - A Novel Nanotechnology-Based Platform to Optimize Combination Cancer Therapies: Rational Development & Improved Delivery Using CombiPlex®
Barry D. Liboiron, PhD; Arthur C. Louie, MD; et al describe how CombiPlex addresses the challenges facing the traditional development path of many contemporary drug combinations and provide clinical proof-of-principle evidence that this approach can yield marked improvements in efficacy and patient outcomes.
Ashland Aids Pharmaceutical Manufacturers With Formulation Services
Pharmaceutical scientists at Ashland understand how polymers interact with complex drug molecules. These experts presented at CPhI India to explain...ADVANCED DELIVERY DEVICES - Implantable Drug-Eluting Devices: A Novel Approach to Patient Care
Samuel D. Trohman, MBA, Joey L. Glassco, Elena Draganoiu, PhD, and Carey Boyum present developmental and commercial examples of non-biodegradable drug-eluting devices, along with the versatile properties of thermoplastic polyurethanes for the development of effective drug delivery systems.
Glenmark Pharmaceuticals' Novel Monoclonal Antibody to Enter Phase II
Glenmark Pharmaceuticals S.A. recently announced that GBR 830, a novel monoclonal antibody has completed clinical Phase I dosing. GBR 830...HOT MELT EXTRUSION - OptiMelt™ Hot Melt Extrusion Technology to Improve Bioavailability of Poorly Soluble Drugs
Sampada Upadhye, PhD, indicates bioavailability enhancement with formulation and dose form flexibility can be achieved through the application of HME technology to produce stable drug formulations and increased development success rates.
